Eurobio Scientific SA (ALERS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.030x

Based on the latest financial reports, Eurobio Scientific SA (ALERS) has a cash flow conversion efficiency ratio of 0.030x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€5.36 Million ≈ $6.26 Million USD) by net assets (€180.85 Million ≈ $211.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ALERS equity to assets ratio to measure how much of total assets are equity-financed.

Eurobio Scientific SA - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Eurobio Scientific SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Eurobio Scientific SA cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Eurobio Scientific SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eurobio Scientific SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hamilton Beach Brands Holding Co Class A NYSE:HBB	0.018x
Hyundai Hcn KO:126560	0.020x
Chargeurs S.A. PA:CRI	0.068x
Turcas Petrol AS IS:TRCAS	-0.015x
Blue Bird Tbk PT JK:BIRD	0.040x
Tong-Tai Machine Tool Co Ltd TW:4526	-0.067x
Ritek Corp TW:2349	-0.009x
Geojit Financial Services Limited NSE:GEOJITFSL	0.018x

Annual Cash Flow Conversion Efficiency for Eurobio Scientific SA (2007–2024)

The table below shows the annual cash flow conversion efficiency of Eurobio Scientific SA from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Eurobio Scientific SA.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€178.85 Million ≈ $209.10 Million	€16.70 Million ≈ $19.53 Million	0.093x	-38.88%
2023-12-31	€175.17 Million ≈ $204.80 Million	€26.77 Million ≈ $31.29 Million	0.153x	-38.74%
2022-12-31	€172.67 Million ≈ $201.87 Million	€43.07 Million ≈ $50.36 Million	0.249x	-39.36%
2021-12-31	€160.22 Million ≈ $187.32 Million	€65.92 Million ≈ $77.06 Million	0.411x	-19.23%
2020-12-31	€107.84 Million ≈ $126.08 Million	€54.93 Million ≈ $64.22 Million	0.509x	+273.22%
2019-12-31	€36.56 Million ≈ $42.75 Million	€4.99 Million ≈ $5.83 Million	0.136x	+872.96%
2018-12-31	€29.62 Million ≈ $34.63 Million	€-523.00K ≈ $-611.44K	-0.018x	-122.61%
2017-12-31	€31.69 Million ≈ $37.05 Million	€2.48 Million ≈ $2.89 Million	0.078x	+128.78%
2016-12-31	€12.23 Million ≈ $14.29 Million	€-3.32 Million ≈ $-3.88 Million	-0.271x	-158.84%
2015-12-31	€23.31 Million ≈ $27.25 Million	€-2.44 Million ≈ $-2.86 Million	-0.105x	+13.43%
2014-12-31	€27.95 Million ≈ $32.67 Million	€-3.38 Million ≈ $-3.96 Million	-0.121x	+49.18%
2013-12-31	€20.56 Million ≈ $24.04 Million	€-4.90 Million ≈ $-5.73 Million	-0.238x	-31.31%
2012-12-31	€24.50 Million ≈ $28.64 Million	€-4.45 Million ≈ $-5.20 Million	-0.182x	+59.12%
2011-12-31	€13.57 Million ≈ $15.86 Million	€-6.02 Million ≈ $-7.04 Million	-0.444x	-46.82%
2010-12-31	€19.19 Million ≈ $22.44 Million	€-5.80 Million ≈ $-6.78 Million	-0.302x	-14.79%
2009-12-31	€25.46 Million ≈ $29.76 Million	€-6.71 Million ≈ $-7.84 Million	-0.263x	+73.33%
2008-12-31	€9.74 Million ≈ $11.39 Million	€-9.62 Million ≈ $-11.24 Million	-0.988x	-261.60%
2007-12-31	€18.07 Million ≈ $21.12 Million	€-4.93 Million ≈ $-5.77 Million	-0.273x	--

About Eurobio Scientific SA

PA:ALERS France Medical Devices

Market Cap

$248.37 Million

€212.44 Million EUR

Market Cap Rank

#15907 Global

#232 in France

Share Price

€21.10

Change (1 day)

+1.93%

52-Week Range

€20.00 - €25.60

All Time High

€28.88